St. Jude pipeline looks promising for future

Although the defibrillator market may be shrinking, St. Jude Medical is continuing to find ways to expand its presence in the medical device community, whether by taking some of a competitor's market share or focusing on new procedures and emerging markets.

In an investor conference call last week, St. Jude said it is focusing on technology for lower-impact heart valve and hypertension procedures. Although the fruits of those technologies may be years away, the company is still growing here-and-now as it gained three percentage points of market share in the last year from its competitors, Medtronic and Boston Scientific. According to CEO Daniel Starks, another four points could come in the next four to six years, mostly from replacement procedures.

- here's the Dow Jones article
- read the WSJ coverage

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.